Hepatocyte growth factor twenty years on: Much more than a growth factor.
about
Cooperative interaction of MUC1 with the HGF/c-Met pathway during hepatocarcinogenesisAntifibrotic therapies to control cardiac fibrosisPharmacological Intervention in Hepatic Stellate Cell Activation and Hepatic FibrosisFibronectin Interaction and Enhancement of Growth Factors: Importance for Wound HealingLigand-triggered resistance to molecular targeted drugs in lung cancer: roles of hepatocyte growth factor and epidermal growth factor receptor ligandsIKKβ acts as a tumor suppressor in cancer-associated fibroblasts during intestinal tumorigenesis.Met receptor tyrosine kinase signaling induces secretion of the angiogenic chemokine interleukin-8/CXCL8 in pancreatic cancerAn allosteric switch for pro-HGF/Met signaling using zymogen activator peptidesEGFR-TKI resistance in NSCLC patients: mechanisms and strategiesGgnbp2 Is Essential for Pregnancy Success via Regulation of Mouse Trophoblast Stem Cell Proliferation and DifferentiationPla2g12b and Hpn are genes identified by mouse ENU mutagenesis that affect HDL cholesterolMicrovesicles derived from human Wharton's jelly mesenchymal stem cells promote human renal cancer cell growth and aggressiveness through induction of hepatocyte growth factor.Pancreatic β-cell proliferation in obesity.Transplantation of HGF gene-engineered skeletal myoblasts improve infarction recovery in a rat myocardial ischemia model.Olive phenolics as c-Met inhibitors: (-)-Oleocanthal attenuates cell proliferation, invasiveness, and tumor growth in breast cancer modelsRole of c-Met/phosphatidylinositol 3-kinase (PI3k)/Akt signaling in hepatocyte growth factor (HGF)-mediated lamellipodia formation, reactive oxygen species (ROS) generation, and motility of lung endothelial cells.Lung fibroblasts accelerate wound closure in human alveolar epithelial cells through hepatocyte growth factor/c-Met signaling.Pretransplant comorbidities predict severity of acute graft-versus-host disease and subsequent mortality.c-Met signaling in the development of tumorigenesis and chemoresistance: potential applications in pancreatic cancerLiver zonation: Novel aspects of its regulation and its impact on homeostasis.Type II transmembrane serine protease gene variants associate with breast cancer.Joint pathology and platelet-rich plasma therapies.Signal transduction pathway analysis in fibromatosis: receptor and nonreceptor tyrosine kinases.HGF Expressing Stem Cells in Usual Interstitial Pneumonia Originate from the Bone Marrow and Are Antifibrotic.Delivery of an engineered HGF fragment in an extracellular matrix-derived hydrogel prevents negative LV remodeling post-myocardial infarctionNovel role for endogenous hepatocyte growth factor in the pathogenesis of intracranial aneurysms.Effects of high intensity training and high volume training on endothelial microparticles and angiogenic growth factorsClinical significance of hepatocyte growth factor/c-Met expression in the assessment of gastric cancer progression.Reciprocal activating crosstalk between c-Met and caveolin 1 promotes invasive phenotype in hepatocellular carcinoma.T160‐phosphorylated CDK2 defines threshold for HGF dependent proliferation in primary hepatocytesMesenchymal stromal cells reset the scatter factor system and cytokine network in experimental kidney transplantation.Microvesicles derived from human umbilical cord mesenchymal stem cells facilitate tubular epithelial cell dedifferentiation and growth via hepatocyte growth factor induction.The secretome of induced pluripotent stem cells reduces lung fibrosis in part by hepatocyte growth factorInfluenza induces IL-8 and GM-CSF secretion by human alveolar epithelial cells through HGF/c-Met and TGF-α/EGFR signalingAssociation of hepatocyte-derived growth factor receptor/caudal type homeobox 2 co-expression with mucosal regeneration in active ulcerative colitisMatriptase protects against experimental colitis and promotes intestinal barrier recoveryImprovement of sepsis by hepatocyte growth factor, an anti-inflammatory regulator: emerging insights and therapeutic potential.Met tyrosine kinase inhibitor, PF-2341066, suppresses growth and invasion of nasopharyngeal carcinomaNecrotic cell-derived high mobility group box 1 attracts antigen-presenting cells but inhibits hepatocyte growth factor-mediated tropism of mesenchymal stem cells for apoptotic cell death.Insulin-Like Growth Factor I (IGF-I) Expressed from an AAV1 Vector Leads to a Complete Reversion of Liver Cirrhosis in Rats.
P2860
Q24298462-A61AFB87-12E8-4D77-8657-DBAE1ECEA0FFQ26745841-B68B5822-6931-4635-ADF6-48FE86C8C162Q26768588-41326DA5-4CC1-4A3F-942E-AE902C39A496Q26798456-EA575C2E-7D40-4759-BD24-109A7B3C24ACQ26829104-449B1A41-0FC2-432C-BCAA-1DA3096F5E1CQ27308754-B6E120F0-DD74-4DFE-852D-34428DA0CD03Q27334957-2B936957-BDF3-4234-B182-34E4081200BBQ27690294-ECF36274-57C7-4889-92A5-4A0924065E10Q28394310-2A47E4A2-3FD9-43A1-AFD9-3160A6E624B0Q28509351-52EE5584-C154-4299-AE0D-4D01D806757DQ28591047-F3F6AEED-0960-4A0A-9D08-223B8FE409D7Q33568086-5D9116C1-F9E4-49C9-BC7B-CBD5280693BEQ33578671-BB08841C-EA56-42A7-A58E-973C2F728BEBQ33620896-20EF29BA-29F2-476F-A0D5-F6A91E840CFFQ33645135-3EFA4C42-4A23-47F4-8C83-7E1ED6DC8E4FQ33676726-96C6E827-9631-4723-B9DE-2BFEFF07AE54Q33840378-9919B4D5-76CF-49B0-B722-5B77A682829AQ33886907-30A8DB57-C449-41E5-BF0C-136F4144186EQ33886974-CC107341-10EE-4528-A09B-018CF54894C2Q33886995-B5BCFE79-C312-4758-8E31-8B9336612938Q33910850-F6D5271D-4D60-4578-A3DC-AD5F91005DB2Q34240837-9A693969-1AB8-4458-9163-294CE4B63DABQ34782409-EA10CAD5-A50D-4590-BC18-24DA54F4C3F1Q34804461-9150D47C-46B8-4C27-B109-61BE34E696F3Q35078379-4B95EDF0-1561-49A0-9D9C-E6B09D66A835Q35079472-8DD4BEC6-D3A5-4BD8-A015-A0B0E26AC5F1Q35158221-E0D16BAB-6B8B-4624-8A75-602EC71C1AF0Q35201636-06261C0E-030D-4592-AC8C-E8843929722CQ35229808-26A71278-4C35-4AE2-A410-D0E0685685C8Q35236730-A2317A05-766F-4371-A9D9-25C06A18019EQ35296873-12C8A015-869E-4D5A-8FC5-E21C30070977Q35582096-9D0D77CD-468F-4E30-9F33-987EAC9F4E37Q35654823-A6BF902C-7682-4057-944C-1AA009E7C8EBQ35672037-5B7EAF3F-245A-45C0-B99A-35C690BF617AQ35729065-85769FC2-02D4-4C33-8BF2-27331BB62B16Q35785774-D981FFBB-B069-44C8-9284-6596B0E2F353Q35821392-0D1B546B-A505-4206-A2D5-EEB8B1AEDEC7Q36014988-4896F2D7-CE7A-4C2A-B8EF-3EBD9CD77576Q36067773-FA8A20CB-BE37-4954-9120-DEC3EDFD41B1Q36141134-A3079F22-46C1-463A-90D6-E5911FE85D15
P2860
Hepatocyte growth factor twenty years on: Much more than a growth factor.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Hepatocyte growth factor twenty years on: Much more than a growth factor.
@en
Hepatocyte growth factor twenty years on: Much more than a growth factor.
@nl
type
label
Hepatocyte growth factor twenty years on: Much more than a growth factor.
@en
Hepatocyte growth factor twenty years on: Much more than a growth factor.
@nl
prefLabel
Hepatocyte growth factor twenty years on: Much more than a growth factor.
@en
Hepatocyte growth factor twenty years on: Much more than a growth factor.
@nl
P2093
P2860
P1476
Hepatocyte growth factor twenty years on: Much more than a growth factor.
@en
P2093
Katsuya Sakai
Kunio Matsumoto
Takahiro Nakamura
Toshikazu Nakamura
P2860
P304
P356
10.1111/J.1440-1746.2010.06549.X
P478
26 Suppl 1
P577
2011-01-01T00:00:00Z